112 related articles for article (PubMed ID: 1425137)
1. Comparison of subcutaneously administered soluble insulin and des-(B26-B30)-insulin-B25-amide in rabbit, pig and healthy man.
Hartmann H; Moesus E; Creutzfeldt W
Diabetes Res Clin Pract; 1992 Jun; 16(3):175-81. PubMed ID: 1425137
[TBL] [Abstract][Full Text] [Related]
2. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
[TBL] [Abstract][Full Text] [Related]
3. Acute metabolic actions of des-(B27-B30)-insulin and related analogues in adult rats.
Hartmann H; Korf J; Ottmers U; Creutzfeldt W
Acta Diabetol; 1993; 30(2):108-14. PubMed ID: 8219258
[TBL] [Abstract][Full Text] [Related]
4. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
Kang S; Brange J; Burch A; Vølund A; Owens DR
Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
[TBL] [Abstract][Full Text] [Related]
5. Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs.
Markussen J; Havelund S; Kurtzhals P; Andersen AS; Halstrøm J; Hasselager E; Larsen UD; Ribel U; Schäffer L; Vad K; Jonassen I
Diabetologia; 1996 Mar; 39(3):281-8. PubMed ID: 8721773
[TBL] [Abstract][Full Text] [Related]
6. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of des-(B26-B30)-insulinamide and related analogues in rat hepatocyte cultures.
Hartmann H; Oberhaus K; Spahr R; Brandenburg D; Creutzfeldt W; Probst I
Diabetologia; 1989 Jul; 32(7):416-20. PubMed ID: 2680697
[TBL] [Abstract][Full Text] [Related]
9. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J
BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064
[TBL] [Abstract][Full Text] [Related]
10. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
11. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
[TBL] [Abstract][Full Text] [Related]
12. Self-association of des-(B26-B30)-insulin. The effect of Ca2+ and some other divalent cations.
Jeffrey PD
Biol Chem Hoppe Seyler; 1986 May; 367(5):363-9. PubMed ID: 3527222
[TBL] [Abstract][Full Text] [Related]
13. Shortened insulin with enhanced in vitro potency.
Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A
Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338
[TBL] [Abstract][Full Text] [Related]
14. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
[TBL] [Abstract][Full Text] [Related]
15. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
[TBL] [Abstract][Full Text] [Related]
17. Action profile of the rapid acting insulin analogue: human insulin B28Asp.
Heinemann L; Heise T; Jorgensen LN; Starke AA
Diabet Med; 1993 Jul; 10(6):535-9. PubMed ID: 8365089
[TBL] [Abstract][Full Text] [Related]
18. Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30.
Markussen J; Diers I; Engesgaard A; Hansen MT; Hougaard P; Langkjaer L; Norris K; Ribel U; Sørensen AR; Sørensen E
Protein Eng; 1987 Jun; 1(3):215-23. PubMed ID: 3333847
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
[TBL] [Abstract][Full Text] [Related]
20. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers.
Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ
Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
